| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |